x

Coronavirus

Vaccine Alliance to Set Aside Up to 100M Doses

GENEVA — Vaccine distribution alliance Gavi says it plans to set aside up to 100 million COVID-19 vaccine doses this year for emergency situations and people in conflict zones.

The Geneva-based public-private partnership says the U.N.-backed program to get the vaccines to people in need around the world, known as COVAX, will allocate 5 percent of the estimated 2 billion doses it expects to receive this year for “high-risk populations in humanitarian settings” and for emergency release in severe outbreaks.

Gavi on Tuesday said its board approved the “COVAX Buffer” initiative for use in places facing “unavoidable gaps in coverage” in places like state failure and conflict.

Former European Union Commission president Jose Manuel Barrosso, the new chairman of the Gavi board, said the move will provide a “safety net” to ensure that people in such places are not excluded from COVAX’s aim to help all high-risk populations.

Release of such emergency doses will be considered once all COVAX participants — 182 countries, including 92 low-income countries and eight territories — are allocated “a base amount” of doses.

RELATED

BEIJING (AP) — Genetic material collected at a Chinese market near where the first human cases of COVID-19 were identified show raccoon dog DNA comingled with the virus, adding evidence to the theory that the virus originated from animals, not from a lab, international experts say.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.